Lind Kevin Robert 4
4 · Longboard Pharmaceuticals, Inc. · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Lind Kevin Robert
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-09+325,850→ 325,850 totalExercise: $4.35Exp: 2033-02-08→ Voting common stock (325,850 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.